INVO Fertility, Inc. (IVF)

Market Cap	1.79M -59.5%
Revenue (ttm)	7.53M +13.8%
Net Income	-7.09M
EPS	-6.80
Shares Out	1.79M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	312,319
Open	1.030
Previous Close	1.030
Day's Range	1.000 - 1.040
52-Week Range	0.900 - 84.396
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 17, 2026

About IVF

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 42
• Stock Exchange: NASDAQ
• Ticker Symbol: IVF
• Website: https://www.invofertility.com

Financial Performance

In 2025, INVO Fertility's revenue was $6.84 million, an increase of 4.73% compared to the previous year's $6.53 million. Losses were -$25.13 million, 164.3% more than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 29, 2026

Data Sources Report a data error